Studies have noted that treatment-naïve patients with GBM have decreased systemic lymphocyte levels, seen both as profound CD4+ count depression, as well as atrophic, T cell-depleted lymphoid organs [142,143]. This evidence concerns the gene CD4 and glioblastoma.